BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12800235)

  • 1. Cross-reactivity of hypervariable region 1 chimera of hepatitis C virus.
    Xiu BS; Ling SG; Song XG; Zhang HQ; Chen K; Zhu CX
    World J Gastroenterol; 2003 Jun; 9(6):1256-60. PubMed ID: 12800235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hepatitis C virus hypervariable region 1 and its clinical significance.
    Zhang XX; Zhang SY; Liu J; Lu ZM; Wang Y
    World J Gastroenterol; 2003 May; 9(5):1003-7. PubMed ID: 12717846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
    Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
    Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a plant-derived subunit vaccine candidate against hepatitis C virus.
    Nemchinov LG; Liang TJ; Rifaat MM; Mazyad HM; Hadidi A; Keith JM
    Arch Virol; 2000; 145(12):2557-73. PubMed ID: 11205105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadly cross-reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library.
    Zhang XX; Deng Q; Zhang SY; Liu J; Cai Q; Lu ZM; Wang Y
    J Med Virol; 2003 Dec; 71(4):511-7. PubMed ID: 14556263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Reactivity of Synthetic Peptides Originated from Hypervariable Region 1 of Hepatitis C Synthetic Consensuses with Egyptian Sera Infected with Hepatitis C Virus Type 4.
    Abdel-Fattah M; Charmy R; Tawfik AR
    Intervirology; 2015; 58(4):232-41. PubMed ID: 26330263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cross-reactive antibody response to HVR1 in chronic hepatitis C.
    Xiu BS; Feng XY; He J; Wang GH; Zhang XY; Zhang HQ; Song XG; Chen K; Ling SG; Zhu CX; Wei L; Rao HY
    World J Gastroenterol; 2010 Sep; 16(35):4460-6. PubMed ID: 20845515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b.
    Majid A; Jackson P; Lawal Z; Pearson GM; Parker H; Alexander GJ; Allain JP; Petrik J
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():317-325. PubMed ID: 10073690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of an HCV-derived multi-epitope peptide antigen containing B-cell HVR1 mimotopes and T-cell conserved epitopes.
    Gao J; Gong Y; Zhao P; Zhu Q; Yang X; Qi Z
    Sci China C Life Sci; 2006 Oct; 49(5):490-9. PubMed ID: 17172057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
    Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
    EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries.
    Zhai W; Davies J; Shang DZ; Chan SW; Allain JP
    J Viral Hepat; 1999 Mar; 6(2):115-24. PubMed ID: 10607222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
    Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
    Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cross reactivity of mimotopes of hepatitis C virus hypervariable region 1].
    Yang M; Zhao P; Bian ZQ; Ren YL; Gong YP; Qi ZT
    Bing Du Xue Bao; 2008 Jul; 24(4):249-54. PubMed ID: 18780625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro evidence that cross-reactive antibodies to C-terminus of hypervariable region 1 do not neutralize heterologous hepatitis C virus.
    Esumi M; Zhou YH; Tanoue T; Tomoguri T; Hayasaka I
    Vaccine; 2002 Aug; 20(25-26):3095-103. PubMed ID: 12163260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus.
    Zhou YH; Moriyama M; Esumi M
    Virology; 1999 Apr; 256(2):360-70. PubMed ID: 10191201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment.
    Del Porto P; Puntoriero G; Scottà C; Nicosia A; Piccolella E
    Virology; 2000 Apr; 269(2):313-24. PubMed ID: 10753710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.